Ledger.Open graph →
SEC Form D · filed June 4, 2014

Coherus BioSciences, Inc

Offering
$65.6M
Sold
$55.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

C. R. Allen · Washington, Washington, D.C.DirectorDecca Guilherme · Red Bank, NJDirectorKim E. Armor · Washington, Washington, D.C.ExecJoseph Hanna · Charleston, SCExecAugust J. Troendle, M.D · Cincinnati, OHDirectorHenri-Claude S. Bailly · Boston, MAExec · DirectorDavid E. Martirano · Boston, MADirectorZaid Ashai · Boston, MADirectorJames S. Eisenstein · Boston, MAExecRobert E. Pantano · Boston, MAExec · DirectorNeal Heble · Philadelphia, PADirectorDavid Han · New York, NYDirectorPetros L. Tsirigotis · New York, NYDirectorJ. M. Lazarus, M.D · Redwood City, CADirectorGeorge G. Montgomery · Redwood City, CAExecS. E. Torres · Morrisville, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗